HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vatalanib (PTK787/ZK 222584) in combination with FOLFOX4 versus FOLFOX4 alone as first-line treatment for colorectal cancer: preliminary results from the CONFIRM-1 trial.

AuthorsPreeta Tyagi
JournalClinical colorectal cancer (Clin Colorectal Cancer) Vol. 5 Issue 1 Pg. 24-6 (May 2005) ISSN: 1533-0028 [Print] United States
PMID15929803 (Publication Type: Clinical Trial, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial)
Chemical References
  • Organoplatinum Compounds
  • Phthalazines
  • Protein Kinase Inhibitors
  • Pyridines
  • vatalanib
  • Leucovorin
  • Fluorouracil
Topics
  • Administration, Oral
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Colorectal Neoplasms (drug therapy)
  • Fluorouracil (administration & dosage)
  • Humans
  • Leucovorin (administration & dosage)
  • Organoplatinum Compounds (administration & dosage)
  • Phthalazines (therapeutic use)
  • Protein Kinase Inhibitors (therapeutic use)
  • Pyridines (therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: